IP Library › Granted Patent US 10,517,852
Granted Patent B2
US 10,517,852 · App. 16/037,560 · Granted Dec 31, 2019

Solid forms of bendamustine hydrochloride

Inventors: Martin Ian Cooper (Foxton, GB); Laurent D. Courvoisier (Thorndale, PA); Mark Eddleston (Chillwell, GB); Robert E. McKean (Chester Springs, PA)
Assignee: Cephalon, Inc.
A61K31/4184A61K9/0019A61K9/14A61K9/19A61K47/26C07D235/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,517,852
App. No.
16/037,560
Granted
Dec 31, 2019
Kind
B2
Abstract

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

Claims (1)

1. A crystalline form of bendamustine hydrochloride that is Form 4 and produces an X-ray powder diffraction pattern having peaks at 7.8, 10.3, 10.8, 15.5, 19.6, and 26.6±0.2 degrees 2θ.

Assignments (1)
CHANGE OF NAME Recorded Jul 26, 2022
From: CEPHALON, INC.
To: CEPHALON LLC
Reel/Frame 060921/0078 →
Continuity (8)
Continuation 15045523 · Feb 17, 2016
Continuation 14531023 · Nov 3, 2014
Continuation 14200738 · Mar 7, 2014
Continuation 13874575 · May 1, 2013
Continuation 13301979 · Nov 22, 2011
Continuation 12411929 · Mar 26, 2009
Provisional Application 61039752 · Mar 26, 2008
Related Publication 20190015390A1 · Jan 17, 2019